Grants per year
Personal profile
Research Interests
Interested in stem cell/bone marrow transplantation for malignant and non-malignant disorders, and patient outcomes after these transplants. Interested in cancer health disparities specifically in hematologic disorders. Interested in global health with improvement in outcomes for hematologic and oncologic conditions in all regions.
Training Experience
| 2009 | Residency, SUNY/State University of New York Downstate Medical Center |
| 2013 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
| 2014 | Fellowship, University of Texas/MD Anderson Cancer Center |
Education/Academic qualification
MS, Northwestern University
… → 2013
MS, Northwestern University
… → 2013
MBBS, University of Lagos
… → 2003
MD, University of Lagos
… → 2003
Research interests
- Blood Cancer (leukemia and lymphomas)
- Global Health
- Health Disparities
- Hematology
- Oncology
- Transplantation
Fingerprint Dive into the research topics where Kehinde Adekola is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 13 Similar Profiles
Cell Transplantation
Medicine & Life Sciences
Transplants
Medicine & Life Sciences
Transplantation
Medicine & Life Sciences
Ritonavir
Medicine & Life Sciences
Metformin
Medicine & Life Sciences
Protein-Tyrosine Kinases
Medicine & Life Sciences
Recurrence
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2014 2023
BMT CTN 1704 - Composite Health Assessment Model for Older Adults: Applying Pre-transplant Comorbidity, Geriatric Assessment, and Biomarkers to Predic
National Marrow Donor Program, National Institutes of Health
8/20/19 → 8/20/23
Project: Research project
Geriatric Assessment
Cell Transplantation
Comorbidity
Biomarkers
Transplants
Prot #KD025-213: Phase 2, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of KD025 in Subjects with Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy (The ROCKstar Study)
Medpace Clinical Research LLC, Kadmon Corporation, LLC
5/16/19 → 5/16/22
Project: Research project
Prot #JZP963-201: A Phase 2, Prospective, Randomized, Open-label Study on the Efficacy of Defibrotide Added to Standard of Care Immunoprophylaxis for the Prevention of Acute Graft-versus-Host-Disease in Adult and Pediatric Patients After Allogeneic Hemato
PPD Investigator Services, LLC, Jazz Pharmaceuticals, Inc.
2/20/19 → 2/20/22
Project: Research project
Exploring the Potential of Dual Kinase JAK 1/2 Inhibitor Ruxolitinib (INC424) with Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis
Icahn School of Medicine at Mount Sinai, National Cancer Institute
7/1/14 → 12/31/18
Project: Research project
Janus Kinases
Primary Myelofibrosis
Cell Transplantation
INCB018424
Research Output 2012 2019
Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation
Sabloff, M., Chhabra, S., Wang, T., Fretham, C., Kekre, N., Abraham, A., Adekola, K., Auletta, J. J., Barker, C., Beitinjaneh, A. M., Bredeson, C., Cahn, J. Y., Diaz, M. A., Freytes, C., Gale, R. P., Ganguly, S., Gergis, U., Guinan, E., Hamilton, B. K., Hashmi, S. & 14 others, , Dec 2019, In : Biology of Blood and Marrow Transplantation. 25, 12, p. 2398-2407 10 p.Research output: Contribution to journal › Article
Whole-Body Irradiation
Cell Transplantation
Confidence Intervals
Recurrence
Mortality
1
Citation
(Scopus)
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation
Brunstein, C. G., Pasquini, M. C., Kim, S., Fei, M., Adekola, K., Ahmed, I., Aljurf, M., Agrawal, V., Auletta, J. J., Battiwalla, M., Bejanyan, N., Bubalo, J., Cerny, J., Chee, L., Ciurea, S. O., Freytes, C., Gadalla, S. M., Gale, R. P., Ganguly, S., Hashmi, S. K. & 22 others, , Mar 2019, In : Biology of Blood and Marrow Transplantation. 25, 3, p. 480-487 8 p.Research output: Contribution to journal › Article
Cell Transplantation
Melphalan
Lymphoma
Drug Therapy
Transplants
It’s all about the CD3+ T-cells: how circulating immune cell subset analyses can predict early relapse in Hodgkin lymphoma
Moreira, J., Platanias, L. C. & Adekola, K., Aug 24 2019, In : Leukemia and Lymphoma. 60, 10, p. 2345-2347 3 p.Research output: Contribution to journal › Comment/debate
Hodgkin Disease
T-Lymphocytes
Recurrence
1
Citation
(Scopus)
Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis
Wood, W. A., Brazauskas, R., Hu, Z. H., Abdel-Azim, H., Ahmed, I. A., Aljurf, M., Badawy, S., Beitinjaneh, A., George, B., Buchbinder, D., Cerny, J., Dedeken, L., Diaz, M. A., Freytes, C. O., Ganguly, S., Gergis, U., Almaguer, D. G., Gupta, A., Hale, G., Hashmi, S. K. & 30 others, , Sep 2018, In : Biology of Blood and Marrow Transplantation. 24, 9, p. 1928-1935 8 p.Research output: Contribution to journal › Article
Cell Transplantation
Human Development
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Cell Survival
Transplants
10
Citations
(Scopus)
Neurocognitive dysfunction in hematopoietic cell transplant recipients: Expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT
Buchbinder, D., Kelly, D. L., Duarte, R. F., Auletta, J. J., Bhatt, N., Byrne, M., Defilipp, Z., Gabriel, M., Mahindra, A., Norkin, M., Schoemans, H., Shah, A. J., Ahmed, I., Atsuta, Y., Basak, G. W., Beattie, S., Bhella, S., Bredeson, C., Bunin, N., Dalal, J. & 27 others, , May 1 2018, In : Bone Marrow Transplantation. 53, 5, p. 535-555 21 p.Research output: Contribution to journal › Review article
Cell Transplantation
Quality of Life
Transplants
Bone Marrow
Morbidity